Eastman Chemical Co
NYSE:EMN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
82.12
113.77
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Eastman Chemical Co
Eastman Chemical Co
Net Issuance of Common Stock
Eastman Chemical Co
Net Issuance of Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Eastman Chemical Co
NYSE:EMN
|
Net Issuance of Common Stock
-$300m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
|
Sherwin-Williams Co
NYSE:SHW
|
Net Issuance of Common Stock
-$1.7B
|
CAGR 3-Years
17%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-3%
|
|
|
International Flavors & Fragrances Inc
NYSE:IFF
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dupont De Nemours Inc
NYSE:DD
|
Net Issuance of Common Stock
-$452m
|
CAGR 3-Years
33%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
Ecolab Inc
NYSE:ECL
|
Net Issuance of Common Stock
-$321.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
|
PPG Industries Inc
NYSE:PPG
|
Net Issuance of Common Stock
-$597m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-2%
|
CAGR 10-Years
6%
|
|
Eastman Chemical Co
Glance View
Eastman Chemical Co., born out of the ash and dust of innovation, traces its roots back to 1920 when George Eastman orchestrated its inception as a vital wing of Kodak. Originally established to secure raw materials for Kodak's photography business, Eastman soon stretched beyond its origins with an eye on the horizons of chemical ingenuity. Over the decades, the company cultivated a vast portfolio, diving into specialty chemicals and advanced materials, far removed from its first endeavors. It became a master at transforming basic chemical building blocks into value-added products that serve myriad industries, from pharmaceuticals and agriculture to consumer products and construction. By capitalizing on the scientific alchemy of catalysis, polymer science, and chemical engineering, Eastman continues to forge pathways into new markets. Navigating the 21st-century landscape, Eastman Chemical has proven itself adept at adapting its sails to the winds of change and sustainability imperatives, an approach paramount to its business strategy. The company operates through several nimble segments, such as Additives & Functional Products, Advanced Materials, Chemical Intermediates, and Fibers, each weaving their unique contribution to the company’s bottom line. These segments transform their chemical wizardry into products like coatings, adhesives, specialty plastics, and fibers, embedded in everyday items and industrial essentials. Holding a keen focus on innovation and client collaboration, Eastman not only maintains its status as a leader in specialty materials but also seeks to boost profitability through efficiency and global expansion, ensuring its long-standing tradition of growth and transformation endures amidst the evolving tapestry of the global economy.
See Also
What is Eastman Chemical Co's Net Issuance of Common Stock?
Net Issuance of Common Stock
-300m
USD
Based on the financial report for Sep 30, 2024, Eastman Chemical Co's Net Issuance of Common Stock amounts to -300m USD.
What is Eastman Chemical Co's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 10Y
5%
Over the last year, the Net Issuance of Common Stock growth was -69%. The average annual Net Issuance of Common Stock growth rates for Eastman Chemical Co have been -10% over the past three years , 3% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet
